Eriko Katsuta Selected Research

Radical Mastectomy

11/2018	Generating a Murine Orthotopic Metastatic Breast Cancer Model and Performing Murine Radical Mastectomy.
11/2017	Murine breast cancer mastectomy model that predicts patient outcomes for drug development.
7/2016	Live animals for preclinical medical student surgical training.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eriko Katsuta Research Topics

Disease

41	Neoplasms (Cancer) 11/2022 - 11/2010
20	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2009
16	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2010
5	Triple Negative Breast Neoplasms 01/2022 - 08/2019
4	Inflammation (Inflammations) 08/2019 - 11/2016
3	Adenocarcinoma 05/2020 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 11/2011
3	Carcinogenesis 01/2019 - 01/2016
3	Lymphatic Metastasis 07/2018 - 11/2011
2	Hepatocellular Carcinoma (Hepatoma) 05/2021 - 09/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 03/2018
2	Obesity 01/2018 - 11/2017
2	Fibrosis (Cirrhosis) 11/2016 - 09/2014
2	Stomach Neoplasms (Stomach Cancer) 11/2012 - 11/2011
2	Colorectal Neoplasms (Colorectal Cancer) 11/2011 - 11/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 09/2020
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	Esophageal Squamous Cell Carcinoma 01/2019
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 07/2018

Drug/Important Bio-Agent (IBA)

6	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 05/2021 - 10/2016
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2016
5	sphingosine kinaseIBA 12/2020 - 10/2016
4	RNA (Ribonucleic Acid)IBA 11/2022 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
4	EnzymesIBA 05/2021 - 11/2017
4	Estrogen ReceptorsIBA 01/2021 - 05/2019
4	Pharmaceutical PreparationsIBA 11/2018 - 07/2011
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2020
3	LipidsIBA 01/2021 - 10/2016
3	Interleukin-6 (Interleukin 6)IBA 05/2020 - 11/2017
2	SphingolipidsIBA 05/2021 - 01/2018
2	CeramidesIBA 05/2021 - 07/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 05/2019
2	Estrogens (Estrogen)FDA Link 10/2019 - 01/2019
2	SphingosineIBA 07/2018 - 10/2016
2	AndrogensIBA 03/2018 - 09/2014
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 11/2017
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2012 - 07/2011
2	Gemcitabine FDA Link 11/2012 - 11/2011
2	Fluorouracil (Carac)FDA LinkGeneric 11/2011 - 11/2010
2	Tumor Biomarkers (Tumor Markers)IBA 11/2011 - 11/2010
1	PlatinumIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	PyrimidinonesIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	pyrimidineIBA 01/2022
1	A73025IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	triplatinNCIBA 01/2021
1	Aconitate Hydratase (Aconitase)IBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	ChemokinesIBA 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	Nuclear Receptor Coactivator 2IBA 01/2021
1	Sirtuin 3IBA 01/2021
1	Histones (Histone)IBA 09/2020
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2020
1	Interleukin-2 (IL2)IBA 05/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2019
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 10/2019
1	Annexin A1IBA 08/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 08/2019
1	MetalsIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	PhosphoenolpyruvateIBA 01/2019
1	Radioisotopes (Radionuclides)IBA 01/2019
1	DeoxyuridineIBA 01/2019
1	Bromodeoxyuridine (BrdU)IBA 01/2019
1	Biological ProductsIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Polo-Like Kinase 1IBA 01/2019
1	Annexin A2 (Annexin II)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019
1	phosphohistidineIBA 01/2019
1	IronIBA 01/2019
1	LuciferasesIBA 11/2018
1	SphingomyelinsIBA 07/2018
1	VimentinIBA 03/2018
1	Cadherins (E-Cadherin)IBA 03/2018
1	CytokinesIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017
1	Sphingosine-1-Phosphate ReceptorsIBA 11/2017
1	saracatinibIBA 11/2017
1	vasectrin IIIIBA 10/2017

Therapy/Procedure

13	Therapeutics 05/2021 - 11/2009
9	Drug Therapy (Chemotherapy) 01/2022 - 11/2010
4	Neoadjuvant Therapy 01/2022 - 05/2019
3	Immunotherapy 01/2021 - 01/2016
3	Radical Mastectomy 11/2018 - 07/2016
3	Mastectomy (Mammectomy) 11/2018 - 11/2010
3	Catheters 11/2012 - 11/2010
1	Cystectomy 01/2022
1	Precision Medicine 01/2022
1	Prostatectomy (Retropubic Prostatectomy) 03/2018